Navigation Links
DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
Date:5/13/2010

eholders," stated Robert Doman, President and Chief Executive Officer.

Paul Hondros, 61, has over 30 years of investment industry experience and is the current President and Chief Executive Officer of AlphaOne Capital Partners, LLC, and its affiliate companies. Prior to his employment at AlphaOne Capital Partners, LLC which he founded in December of 2008, he was the President and Chief Executive Officer of Gartmore Global Investments and President and Chief Executive Officer of the Gartmore Group, a global asset management company, which oversaw $85 billion in assets. In 1998, he founded Villanova Capital, Inc., which operated until 2003, when it was merged into Gartmore Investment Management plc.  From 1990-1997 he was the President and Chief Executive Officer of Fidelity Investments' Institutional Services Company and also as the President and Chief Executive Officer of its Individual Investors groups. Early in his career, Mr. Hondros worked with SEI Investments, Inc., a global investment management, software, and mutual fund services company, where he began his career as a computer programmer, eventually rising to Executive Vice President of its Financial Services Division.  Mr. Hondros is also the Chairman of the Board of Trustees of St. Joseph's University, from which he earned his bachelor's degree in history, and where he and Mrs. Hondros recently founded The Kinney Center for Autism Studies.

Alfred Altomari, 51, was Chief Executive Officer of Barrier Therapeutics, Inc. a specialty pharmaceutical company focused in dermatology from April 2008, and a member of the Company's Board of Directors from January 2008, until the sale of the company to GlaxoSmithKline plc in August 2008
'/>"/>

SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
2. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
3. Jazz Pharmaceuticals Announces Public Offering of Common Stock
4. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
5. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
6. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on May 17
7. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
8. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
9. DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
10. Anti-Fibrotic Data from Amira Pharmaceuticals LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
11. ADVENTRX Pharmaceuticals Announces Closing of Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC ... guide with accompanying instrumentation to place and insert the ... the soft tissue (e.g. ligament) repair or reconstruction as ... heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... 2011 Spherix Incorporated (NASDAQ: SPEX ) ... metabolic syndrome and atherosclerosis, and providers of technical and ... companies -- today announced that Dr. Claire Kruger, Chief ... presenting a corporate overview at the Rodman & Renshaw ...
... Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals ... Executive Officer, will present at the Rodman and Renshaw ... 2:25pm ET at the Waldorf Astoria Hotel in New ... Founded in 2008, Omthera Pharmaceuticals, Inc. ...
Cached Medicine Technology:Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... SILVER SPRING, Md., Dec. 24 The American Nurses Association (ANA), ... for passing H.R. 3590, " The Patient Protection and Affordable ... vote of 60-39. ANA had urged passage of the legislation and ... members of Congress, was read on the Senate floor by Majority ...
... , , WASHINGTON, Dec. 24 ... Senate voted to pass the Patient Protection and Affordable Care ... bill on Christmas Eve, after overcoming a series of procedural ... stop the bill from ever reaching the Senate floor for ...
... Dec. 24 The American ... of legislation that holds the promise of more comprehensive coverage ... those without. , We are pleased that the ... our association,s principles for comprehensive health reform, and that the ...
... 24 The following statement is attributable to J. James ... Senate took an historic vote to improve our nation,s health ... strengthening the private insurance market to better serve the patients ... the bill because it contains a number of key improvements ...
... well-tolerated, researchers say , WEDNESDAY, Dec. 23 (HealthDay News) -- ... an effective treatment for Ewing,s sarcoma, a cancer that affects ... boys. , The drug must undergo two more phases of ... 23 online edition of The Lancet Oncology . , ...
... before proposal can become law , THURSDAY, Dec. 24 (HealthDay ... Eve gift on Thursday with passage of a landmark health ... Americans. , Obama said the Senate bill contains 95 percent ... inauguration on Jan. 20. "Every single criteria for reform that ...
Cached Medicine News:Health News:Senate Passes Landmark Health Care Reform Bill 2Health News:DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People 2Health News:APA Statement on Senate Passage of Health Care Reform Legislation 2Health News:AMA: Senate Bill Passage Historic, More Work to Do in Conference 2Health News:Senate Passes Health Reform Package 2Health News:Senate Passes Health Reform Package 3Health News:Senate Passes Health Reform Package 4
... SuperAnchors are titanium alloy implants ... to bone. They are indicated ... required. The SuperAnchor uses four ... while maintaining small size. The ...
The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
... protection' -- providing complete protection from initial ... with side branches. , ,Proxis is ... not require the attachment or exchange of ... ,Proxis is compatible with all standard ...
... electrophysiology system on the market today, the ... patented "C inside a C" design offering ... ultimate in patient access and flexibility. Usable ... minimizes equipment footprint and can be parked ...
Medicine Products: